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Simple Summary: Jasonia glutinosa (L.) DC or rock tea (RT) is a plant traditionally used to treat
different pathologies. In this study the neuroprotective potential of an ethanolic extract of RT is
analyzed. Caenorhabditis elegans model and in vitro assays with relevant central nervous system
enzymes were used. The results showed antioxidant and neuroprotective potential of this plant.
Abstract: In traditional medicine, Jasonia glutinosa (L.) DC or rock tea (RT) has been mainly used to
treat digestive and respiratory pathologies but also as an antimicrobial or an antidepressant herbal
remedy. An ethanolic extract of RT has been demonstrated to have antioxidant and anti-inflammatory
effects, which may be explained by its phytochemical profile, rich in polyphenols and pigments. The
aim of this study is to investigate the neuroprotective potential of RT. For this purpose, the ethanolic
extract of RT is assayed in Caenorhabditis elegans (C. elegans) as an in vivo model, and through in vitro
assays using monoamine oxidase A, tyrosinase and acetylcholinesterase as enzymes. The RT extract
reduces juglone-induced oxidative stress in worms and increases the lifespan and prevents paralysis
of C. elegans CL4176, a model of Alzheimer’s disease; the extract is also able to inhibit enzymes
such as acetylcholinesterase, monoamine oxidase A and tyrosinase in vitro. Together these results
demonstrate that Jasonia glutinosa is a good candidate with antioxidant and neuroprotective potential
for the development of new products with pharmaceutical interests.
Keywords: medicinal plants; C. elegans; acetylcholinesterase; monoamine oxidase A; tyrosinase;
herbal medicine; lifespan
1. Introduction
Jasonia glutinosa (L.) DC. (Compositae), whose popular name is “té de roca” (rock
tea, RT), is a medicinal plant distributed in Mediterranean countries, mainly Spain and
France [1]. Ethnobotanical studies on this plant report that its main use, as an infusion, is
for the treatment of diarrhea, dyspepsia or abdominal pain [2]. These digestive properties
were demonstrated for the first time in a murine model of colitis [3,4]. In these studies, the
oral administration of an ethanolic extract of RT (5, 25 and 50 mg/kg) ameliorated colitis
symptomatology, prevented the macroscopic damage and histological changes induced
by dextran sulfate sodium in mice and normalized the intestinal contractibility and the
intestinal total transit disrupted by the colitis [3,4].
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In addition to its use as a digestive, J. glutinosa has been widely used for the treatment
of respiratory or infective pathologies, hypertension, pain, emesis or even mood disor-
ders [2,5–7]. Different studies reported an ethnopharmacological use of RT as a “stimulant”,
capable of improving mood and clearing the mind [6,7].
Some of these effects could be explained by anti-inflammatory [4,8] or antioxidant
effects [4,5,9], which are related to its phytochemical composition. A recent in vivo study
has shown that dietary supplementation with RT (10 or 30%) for 15 or 30 days in sea
bream (Sparus aurata L.) improves short-term immunostimulatory capacity (15 days) and
maintains antioxidant capacity in the long-term (30 days) [10].
Different studies have shown that J. glutinosa is rich in polyphenols, terpenes, esters,
alkanes, lactones or flavonol glucopyranoside [1,4,9]. High-performance liquid chromatog-
raphy with a diode-array detector (HPCL-DAD) analysis of the ethanolic extract of RT
showed a rich content of phenolic compounds (134.4 mg/g, dry extract) and pigments
(0.27 mg/g, dry extract) (Figure 1). Among the 15 phenolic compounds detected, 10 were
phenolic acids and 5 flavones. 3,4-di-O-caffeoylquinic acid, 3,5-di-O-caffeoylquinic acid,
4,5-di-O-caffeoylquinic acid, 1,5-di-O-caffeoylquinic acid were the phenolic acids most rep-
resented (70% of the total phenolic content). The most abundant flavonoid is quercetin-3-O-
galactoside (50% of total flavonoid). In respect to pigments, two carotenoids, chlorophylls
and xanthophylls were detected. Lutein represented 55% of the total pigments [4].
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Figure 1. J. glutinosa photography taken by authors and the main phenolic compounds of the extract. 
Oxidative stress and inflammation have been linked to the aging process as triggers 
of various diseases, including neurodegeneration. J. glutinosa, with a phytochemical com-
position rich in polyphenols, has previously demonstrated antioxidant and anti-inflam-
matory effects, and its use as an antidepressant has also been reported by certain inhabit-
ants of Spain. However, there are no scientific reports showing the potential of RT as a 
neuro-therapeutic agent. Therefore, the objective of this work is to study the antioxidant 
and neuroprotective activity of RT extract in a Caenorhabditis elegans (C. elegans) model, 
studying the effect of J. glutinosa on stress resistance, lifespan and amyloid toxicity and in 
vitro analyzing its ability to inhibit the enzymes of the nervous system such as acetylcho-
linesterase (AChE), monoamine oxidase A (MAO-A) and tyrosinase (TYR), involved in 
neurotransmitters’ metabolism. These enzymes participate in the elimination of biogenic 
amines such as acetylcholine, serotonin and catecholamines (dopamine, epinephrine, 
norepinephrine), which are involved in the development of different pathologies of the 
nervous system such as Alzheimer’s, Huntington’s and Parkinson’s. Therefore, the inhib-
itory substances of these enzymes could help the treatment of these diseases. 
Figure 1. J. glutinosa photography taken by authors and the main phenolic compounds of the extract.
Oxidative stress and inflammation have been linked to the aging process as triggers of
various diseases, including neurodegeneration. J. glutinosa, with a phytochemical composi-
tion rich in polyphenols, has previously demonstrated antioxidant and anti-inflammatory
effects, and its use as an antidepressant has also been reported by certain inhabitants of
Spain. However, there are no scientific reports showing the potential of RT as a neuro-
therapeutic agent. Therefore, the objective of this work is to study the antioxidant and
neuroprotective activity of RT extract in a Caenorhabditis elegans (C. elegans) model, studying
the effect of J. glutinosa on stress resistance, lifespan and amyloid toxicity and in vitro ana-
lyzing its ability to inhibit the enzymes of the nervous system such as acetylcholinesterase
(AChE), monoamine oxidase A (MAO-A) and tyrosinase (TYR), involved in neurotransmit-
ters’ metabolism. These enzymes participate in the elimination of biogenic amines such
as acetylcholine, serotonin and catecholamines (dopamine, epinephrine, norepinephrine),
which are involved in the development of different pathologies of the nervous system such
as Alzheimer’s, Huntington’s and Parkinson’s. Therefore, the inhibitory substances of
these enzymes could help the treatment of these diseases.
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2. Materials and Methods
2.1. Reagents and Chemicals
The following chemical reagents: gallic acid, xanthine, NBT (nitroblue tetrazolium), xan-
thine oxidase, DPPH (2,2 Diphenyl 1 picrylhydrazyl), galantamine, ATCI (acetylthiocholine
iodide), DTNB (5,5′-dithiobis-(2-nitrobenzoic acid)), Tris, vanillic acid, 4-aminoantipyrine,
horseradish peroxidase, acetylcholinesterase, tyramine, MAO-A, L-DOPA (levodopa) and
tyrosinase were obtained through Sigma-Aldrich (Madrid, Spain). Clorgyline and α-Kojic
acid were sourced from Cymit quimica (Barcelona, Spain). Na2CO3, HCl, NaCl, Methanol
and potassium phosphate were acquired from Panreac (Barcelona, Spain). Juglone (5-
hydroxy-1,4-naphthoquinone) and FUdR (5-fluoro-2′-deoxyuridine) were sourced from
Alfa Aesar (Ward Hill, MA, USA). C. elegans strains and Escherichia coli OP50 were obtained
from the Caenorhabditis Genetics Center (CGC, Minneapolis, MN, USA).
2.2. Plant Material and Extraction
Jasonia glutinosa ethanolic extract was obtained as described in Valero et al., (2015) [11]
and a plant voucher was kept in the Universidad San Jorge (ref. 001-2012). The ethanolic
extract was analyzed phytochemically in a previous author’s study using HPLC-DAD,
determining its composition in phenolic compounds and pigments [4].
2.3. Caenorhabditis elegans Studies
2.3.1. C. elegans Strains and Maintenance Conditions
This study used the wild-type strain of C. elegans (N2) and a transgenic strain (CL4176
(smg-1 ts 131 (myo-3/Aβ1–42 long 3′-UTR)). The C. elegans CL4176 strain contains a
temperature-sensitive transgene that expresses the human amyloid peptide β1–42 in mus-
cle, which causes paralysis in worms.
The strains were maintained at 16 ◦C (CL4176) or at 20 ◦C (N2) on nematode growth
media (NGM) agar plates seeded with Escherichia coli OP50 as a food source. Synchronized
worms were obtained using an alkali-bleaching method [12] for the N2 strain and egg-
laying for the CL4176 strains.
2.3.2. Assessment of Resistance to Lethal Oxidative Stress
Synchronized L1 worms were cultivated in NGM agar plates in the presence of differ-
ent concentrations of RT extract (5, 10, 20 and 50 µg/mL) or in its absence (control). Under
these conditions, the worms were incubated at 20 ◦C until the first day of adulthood. RT-
treated and control adult worms were washed with sterile water and transferred to 96-well
microplate with NGM agar containing 150 µM juglone (5-hydroxy-1,4-naphthoquinone),
which produces lethal oxidative stress. After an incubation period of 24 h at 20 ◦C, survival
was evaluated by the response to a mechanical stimulus [13]. The number of alive and
dead worms was recorded and the survival rate % (% SR) was calculated:
% SR = (Nº of worms alive x 100)/Total number of worms (1)
Each concentration was tested in triplicate and 100 nematodes were used per assay.
2.3.3. Lifespan Analysis
The lifespan of the wild-type C. elegans (N2) was tested using different concentrations
of RT (5, 10, 20, 50 and 100 µg/mL) and compared with untreated controls following the
method of Solis and Petrascheck [14]. Synchronized wild-type L1 larvae were transferred to
96-well plates (7–18 worms/well) and were cultured in an S-complete medium containing
E. coli OP50 (1.2 × 109 bacteria/mL). On the first day of adulthood, FUdR (0.06 mM) was
added to sterilize the adults (day 0). RT extracts were added 24 h later. Survival of nema-
todes was scored every two or three days. The scoring method was the same as used for the
juglone oxidative stressed assays. Results are expressed as survival rate % (Equation (1))
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and mean lifespan. Each assay was repeated three times and used 150 nematodes per
condition.
2.3.4. Paralysis Assay
In vivo neuroprotective effects of RT extract were evaluated using the strain CL4176
according to previous research protocols [15]. The strain CL4176 was egg-synchronized
onto the NGM plates seeded with E. coli containing 0, 5, 10 and 25 µg/mL of the RT extract
and cultured at 16 ◦C. The temperature was changed to 25 ◦C to induce expression of the
amyloid-β (Aβ) transgene 38 h later (day 0). Paralysis was scored twice a day for five
days [16]. Worms that exhibited pharyngeal pumping, but did not move, or only moved
the head after being touched with a platinum wire, were scored as paralyzed. The test was
performed with 100 nematodes per condition.
2.4. Bioassays Regarding CNS Enzymes
2.4.1. Acetylcholinesterase Inhibition
Ellman’s method was performed in 96-well microplates using a microplate reader
to measure absorbance as previously described [17]. Each assay well contained a mix-
ture of 25 µL 15 mM ATCI in Milipore water, 125 µL 3 mM DTNB in buffer C (50 mM
Tris-HCl, pH = 8, 0.1 M NaCl, 0.02 M MgCl2 6H2O), 50 µL buffer B (50 mM Tris-HCl,
pH = 8, 0.1% bovine serum) and 25 µL RT extract at different concentrations (20.00, 10.00,
5.00, 2.50, 1.25 and 0.63 µg/mL) in buffer A (50 mM Tris-HCl, pH = 8). At last, 25 µL
AChE enzyme (0.22 U/L) was added to begin the reaction. Controls and blanks were
performed, containing buffer A instead of samples and a buffer instead of the enzyme,
respectively. Absorbance was read 13 times every 13 s at 405 nm. Galantamine was used as
a reference inhibitor.
2.4.2. Monoamine Oxidase A Inhibition
The MAO-A activity was performed in a 96-well microplate using a technique pre-
viously described [18]. The assay mixture contained 50 µL RT extract at different concen-
trations (0.0001, 0.0010, 0.0100, 0.1000, 1.0000 and 10.0000 mg/mL), 50 µL chromogenic
solution (0.8 mM vanillic acid, 417 mM 4-aminoantipyrine and 4 U/mL horseradish peroxi-
dase in potassium phosphate buffer pH = 7.6.), 100 µL 3 mM tyramine and 50 µL 8 U/mL
MAO-A. Controls and blanks were also performed, with solvent instead of samples and a
buffer instead of the enzyme, respectively. The absorbance was read at 490 nm every 5 min
for 30 min. Clorgyline was used as a reference inhibitor.
2.4.3. Tyrosinase Inhibition
The TYR activity was assessed in 96-well microplates using a procedure previously
described [19]. The reaction mixture contained 10 µL RT extract at different concentrations
(0.001, 0.010, 0.100, 0.500, 1.000, 2.500 and 5.000 mg/mL), 40 µL of L-DOPA, 80 µL phosphate
buffer, pH = 6.8 and 40 µL tyrosinase; these were mixed in each well. Controls and blanks
were also performed with 50 µL solvent instead of samples and 50 µL buffer instead of the
enzyme, respectively. Absorbance was read at 475 nm. α-Kojic acid was used as a reference
inhibitor.
2.5. Statistical Analysis
Data were expressed as mean ± SEM and for statistical analysis, GraphPad Prism
version 6.0c (GraphPad Software, San Diego, CA, USA) was used. Extract concentration
was required to inhibit 50% of the activity of the nervous system enzymes, IC50; this was
estimated using non-linear regression. ANOVA following by Tukey’s multiple comparisons
test were used to evaluate resistance to oxidative stress. Lifespan and paralysis curves were
tested using log-rank for significant fit to Kaplan–Meier survival curves. The significance
level was set to p < 0.05.
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3. Results
3.1. Rock Tea Extract Improved the Stress Resistance of C. elegans
To evaluate the antioxidant effect of J. glutinosa, wild-type C. elegans were pre-treated
with RT extract (5, 10, 20 and 50 µg/mL) for 24 h and then exposed to a lethal dose of
juglone, a natural pro-oxidant. As Figure 2 shows, this treatment resulted in 0.92% ± 0.52
survival of the control group. Pre-treatment with RT extract improved the survival rate of
the worms in a dose-dependent manner. Groups pre-treated with the highest doses of RT
extract, 20 and 50 µg/mL, significantly increased the survival rate compared to the control
group, with rates of 9.15% ± 2.13 (p < 0.001) and 10.69% ± 2.51 (p < 0.0001), respectively.
These results indicate that the RT extract improves oxidative stress resistance in C. elegans,
protecting them from oxidative stress.
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Figure 2. Rock tea (RT) extract increases the survival of wild-type C. elegans exposed to lethal
oxidative stress. L1 worms were incubated on treatment plates with different doses of RT (5, 10,
20 and 50 µg/mL) until they reached adulthood a d then exposed to juglone (150 µM) for 24 h.
The results repres nt the mean ± SEM of the values from three independent experiments. The
significance for the differences between the control and pre-treated worms is *** p < 0.001.
3.2. Rock Tea Extract Increased C. elegans Lifespan
With the object to study the effect of RT extract on lifespan, wild-type C. elegans grown
at 20 ◦C in a liquid medium containing different doses of RT (5, 10, 20, 50 and 100 µg/mL)
were used. C. elegans is a model widely used to study aging and age-related disorders
due to the good conservation of the biochemical pathways and their short life cycle [20].
The lifespan curves showed that RT extract increases the lifespan of the worms in a dose-
dependent manner (Figure 3). Significant differences were found (p < 0.05) in survival
curves between the control group and the worms treated with 100 µg/mL of RT extract
(12.8 ± 0.56 days vs. 14.7 ± 0.58 days, respectively). The maximum lifespan, understood as
the average lifespan of 10% of each population living longer, increased by 11.36% at doses
of 20 and 50 µg/mL of RT and 13.81% at the dose of 100 µg/mL of RT with respect to the
control. These results show that RT extract presents a positive effect on C. elegans lifespan.
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Figure 3. Lifespan curves of wild-type Caenorhabditis elegans (C. elegans) in a liquid medium supplemented with different
concentrations of RT extract (0–100 µg/mL) at 20 ◦C. Synchronized worms were exposed to the extract from the second
day of adulthood (day one). Scoring of su vival was carried out three times per week until all worms died. Th results are
representative of three independent biological replicates. The curves were analyzed using a long-rank test. Differ nc s
in the survival curves between the treatment and control groups were found at the dose of 100 µg/mL, with a p-value
of 0.0153.
The means of lifespan were 12.8 ± 0.56 days in the control and 13 ± 0.57, 13 ± 0.56,
13.45 ± 0.58, 13.42 ± 0.57 and 14.7 ± 0.55 days in the RT 5, 10, 20, 50 and 100 µg/mL
groups, respectively. The results of lifespan experiments were analyzed using the Kaplan-
Meier survival model and for significance by means of a log-rank pairwise comparison
test between the control and treatment groups. Differences in survival curves between the
treatment and control groups were found for 100 µg/mL with a p-value of 0.0153.
3.3. Rock Tea Extract Delays the Onset of Paralysis Induced by Aβ Peptide
Although there are multiple factors involved in Alzheimer’s disease, numerous studies
have shown that neuronal accumulation of the Aβ peptide plays a central role in the
development of the disease [21]. To further investigate the in vivo neuroprotective effect of
rock tea, an examination was carried out as to whether diet supplementation may affect the
progression of paralysis induced by Aβ toxicity in the C. elegans transgenic strain CL4176.
This strain has proven to be a good model for screening potential neuroprotective natural
products [15,22,23]. Nematodes were exposed to different concentrations of RT extract
(5, 10 and 25 µg/mL) from the egg stage. Then, human Aβ expression was induced by a
temperature upshift that makes worms paralyze over time. The time to develop paralysis
was analyzed using survival curves (Figure 4).
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However, betwee differen groups treated with RT extract, n significant differences
wer found in PT50 at 43 h. According o HR (hazard ratio) value obta ned by log-rank
analysis (0.76; 0.72 nd 0.78), the RT extract significantly reduced the risk of paralysis by
23%, 28% and 21% in worms treated with 5, 10 and 25 µg/mL RT xtract concentration,
respectively.
3.4. Bioassays Regarding CNS Enzymes
The AChE, MAO-A and TYR enzymes are involved in processes that regulate neu-
rotransmission in the CNS. RT extract was able to inhibit all the enzymes at high doses,
although the dose-response curve was shifted to the right with respect to the reference
substances for each enzyme (Figure 5). AChE inhibition of RT extract is achieved at high
doses, with an IC50 of 4.5 mg/mL for RT (Figure 5B). The galantamine IC50 for AChE
inhibition was 0.1 mg/mL. RT extract also revealed the potential to achieve a total inhibi-
tion of MAO-A (Figure 5B). RT extract IC50 was 76.34 µg/mL, a little far from that of the
reference inhibitor, clorgyline, which was 0.12 µg/mL. Finally, RT extract also showed the
inhibitory potential of TYR in a dose-dependent manner (Figure 5C). The extract reached
100% enzyme inhibition at a high dose, 5 mg/mL, and the IC50 of the assay were 1.05 and
0.004 mg/mL for RT extract and kojic acid, respectively.
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4. Discussion
This study shows, for the first time, the neuroprotective effect of Jasonia glutinosa ex-
tract using different types of in vitro and in vivo bioassays. The results obtained demonstrate
that RT extract prevented oxidative stress, increased the lifespan and delayed paralysis of
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the transgenic amyloid C. elegans. In addition, the extract inhibited enzymes of the nervous
system such as acetylcholinesterase, monoamine oxidase A and tyrosinase.
Various studies have associated reactive oxygen species with the pathogenesis of
Alzheimer’s disease (AD) by showing that reactive oxygen species promote the formation
and accumulation of the β-amyloid peptide and hyperphosphorylation of Tau. On the other
hand, oxidative stress is associated with aging. Many theories try to explain the connection,
but it is complicated due to its multifactorial etiology. The so-called “Oxi-Inflamm-Aging”
theory explains the events that occur during aging and the appearance of diseases related to
it; during cellular aging, senescent cells produce pro-inflammatory cytokines that produce
chronic systemic inflammation (“inflamm-aging”), leading to an increase in free radicals.
Similarly, oxidative stress produces states of inflammation due to the impaired immune
system, creating a vicious circle between oxidative stress, inflammation and aging. This
process has been implicated in multiple disease states, such as cardiovascular disease,
cancer, neurodegenerative diseases, diabetes or respiratory diseases [24,25]. Oxidative
stress, β-amyloid peptide accumulation the lifespan have been correlated in the C. elegans
model [26,27], making it an excellent model to study the bioactive properties of substances
with neuroprotective potential.
Different RT extracts have shown anti-inflammatory effects [4,10] and a high capacity
to eliminate superoxide and DPPH radicals [4,5,9]. Furthermore, one in vivo study showed
these antioxidant properties by decreasing HSP70 levels, increasing peroxidase activity
and upregulating the Nrf-2 transcription factor, producing an increase in the expression
of antioxidant enzymes such as catalase and superoxide dismutase in fish [10]. These
properties, which could be explained by its rich composition in phenolic acids, flavonoids
and pigments, make RT an ideal candidate as a neuroprotective natural agent.
Thus, the RT extract has demonstrated antioxidant properties and lifespan extension
in C. elegans in a similar manner to quercetin or kaempferol, two flavonoids present in the
extract. The phytochemical analysis of the ethanolic extract showed a composition rich in
phenolic compounds and pigments [4]. Of the phenolic compounds identified, the most
representative were the hydroxycinnamic acids derived from caffeoylquinic acid, repre-
sented mainly by 3,4-di-O, 3,5-di-O (40.95 mg/g of dry extract), 1,5-di-O (24.73 mg/g of dry
extract) and 4,5-di-O caffeoylquinic acids (23.14 mg/g of dry extract). Of the flavonoids, the
most representative compound was quercetin-3-O-galactoside (15.16 mg/g of dry extract).
In addition, pigments in the extract were determined for the first time, highlighting the
presence of carotenoids and chlorophylls, lutein being the most representative, with content
greater than 55% of the total.
The treatment of C. elegans with quercetin or its methyl derivates, isorhamnetin and
tamarixetin (200 µM), increased worm survival rate under exposure to juglone (150 µM,
24 h exposure). Quercetin showed a greater capacity than methyl derivatives in decreasing
oxidative proteins compared to untreated worms. Isorhamnetine showed greater protection
(16%) compared to quercetin and tamarixetine (11%), prolonging the mean lifespan of the
worms compared to the control worms [13]. These results were similar to those obtained by
Kampkötter and colleagues (2008), who demonstrated that quercetin (100 µM) enhanced the
percentage of survival against oxidative stress (juglone 150 µM, 72 h) by 19% and the mean
lifespan by 15% of worms compared to the untreated worms [28]. Furthermore, worms
pre-treated with kaempferol showed diminished oxidative stress and less accumulation of
reactive oxygen species [29]. Kaempferol and quercetin showed scavenging capacity in
mitochondrial reactive oxygen species levels, without affecting lifespan in mev-1 mutant
worms, a mutation that increases sensitivity to oxidative stress and reduces lifespan [30].
The effect on lifespan may be explained by the antioxidant effect of these compounds
and/or by other complementary mechanisms, independent of antioxidant properties, such
as stress-sensitive signaling pathways.
One of the main key regulatory pathways in C. elegans lifespan and the response to
oxidative stress is the insulin/insulin-like growth factor (IGF-1) signaling (IIS) pathway,
as well as the activation of different transcription factors such as DAF-16/FoxO, HSF-
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1 and SKN-1/Nrf-2 that regulate stress-related genes as antioxidant enzymes. Several
studies have shown that quercetin and kaempferol produced a translocation of DAF-
16 from the cytosol to the nucleus in transgenic C. elegans, increasing the expression of
defense proteins [28–30], the role of these DAF-16 target genes in longevity is unclear.
Different studies have shown that transcription of this factor may not be responsible for
the effect of flavonoids on worm lifespan, since quercetin-treated daf-16 deletion mutants
increased survival in comparison with the control [30–32]. It has recently been shown that
resistance to oxidative stress by quercetin in worms would implicate genes involved in
the IIS pathway such as age-1, akt-1, akt-2, daf-18, sgk-1, daf-2 and skn-1, independent of
transcription factors such as DAF-16 and HSF-1.
Other important compounds in RT extract are caffeoylquinic acids (CQAs), which
are emerging as an interesting group of bioactive compounds with high potential as
neuroprotective agents. These compounds have been shown to possess strong antioxidant
and neuroprotective properties in vitro and in vivo. CQAs have also been shown to improve
cognitive impairment in several rodent models of AD [33]. Recently, Chen et al. [34] showed
that 1,5-O-dicaffeoyl-3-O-(4-malic acid methylester)–quinic acid (MQA), a derivative of
caffeoylquinic acid, can protect against ischemic brain injury in rats. This neuroprotective
effect may involve the inhibition of cell apoptosis due to p38 activation, the increase of the
Bcl-2/Bax ratio and the modulation of NFk-B1 and caspase-3 expression. Furthermore, the
observed decrease in lipid peroxidation suggests that the antioxidant activity of MQA could
also contribute to the protective effect against cerebral ischemia. The association between
antioxidant effects and neuroprotection has been previously demonstrated for other CQAs.
Thus 3-O-caffeoylquinic acid and caffeic acid treatment improved memory in the mouse
model of Aβ accumulation by the inhibition of oxidative stress, inflammation and apoptosis
through the p38 mitogen-activated protein kinase (MAPK) signaling pathway [35,36].
Similarly, Chu et al. [37] observed that a flavone-rich extract of Tetrastigma hemsleyanum
whose major components were 3-caffeoylquinic acid, 5-caffeoylquinic acid and quercetin-3-
O-rutinoside, and kaempferol-3-O-rutinoside could attenuate glutamate-induced toxicity
in PC12 cells and C. elegans. This extract lessened genotoxicity, relieved oxidative stress and
recovered mitochondrial functions in PC12 cells via the MAPK pathway by suppressing the
over-phosphorylation of ERK and p38. Furthermore, treatment suppressed O2- generation,
reduced GSH depletion and partially restored the normal motility lost after the glutamic
acid exposition in C. elegans. Therefore, antioxidant properties could explain the positive
effect of J. glutinosa extract in increasing the lifespan in N2 and transgenic C. elegans
(CL4176 strain).
As mentioned above, oxidative stress and the malfunction of specific enzymes related
to neurotransmitter effects, as AChE, are involved in the development of the pathogenesis
of AD. The accumulation of Aβ peptide caused by free radicals would result in neuron
dysfunction and death. Different works have shown that phenolic compounds present
neuroprotective activity, decreasing the deleterious effects of oxidative stress, increasing
ACh availability, reducing the anti-inflammatory effect and interacting directly with Aβ
peptides inhibit their aggregation and oligomerization [15,23,38,39]. The reduction of the
IIS pathway and expression of genes as DAF-16, HSF-1, HSP-16 and Nrf2/SKN-1 have
also been related to a neuroprotective effect by decreasing the expression of Aβ peptides
and improved the paralysis and lifespan in a C. elegans model of AD [40]. These results
show that RT extract decreases the risk of paralysis in transgenic strain CL4176, and its
neuroprotective effect can be explained by the synergic antioxidant and neuroprotective
activities of phenolic acids and flavonoids.
On the other hand, C. elegans present numerous neurotransmitters, some of which are
implicated in different pathologies of the nervous system such as ACh, dopamine, GABA
or glutamate [41]. RT extract has demonstrated the ability to inhibit the AChE, MAO and
TYR enzymes, which could explain its traditional uses as a stimulant, memory enhancer
or antidepressant, reinforcing its neuroprotective role. Others isolated extracts of plants
and flavonoids have demonstrated the capacity to inhibit CNS enzymes [15,18,23,42,43]
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and decrease the toxicity by Aβ accumulation [15,23,38,44]. Due to these mechanisms,
many natural products have neurotherapeutic potential for the prevention and treatment
of different CNS disorders.
5. Conclusions
Jasonia glutinosa is a medicinal plant with a wide range of traditional uses. The neu-
rotherapeutic potential of a polyphenolic extract has here been demonstrated in different
models due to its protective activity against oxidative stress and the capacity to inhibit
β-amyloid aggregation in C. elegans. This herbal extract has also shown the inhibitory
capacity of nervous system enzymes, which might explain, from an in vitro perspective,
possible mechanisms of its use as a stimulant and antidepressant. All in all, this plant
species as well as its extracts and bioactive compounds are worthy of further investigation
for the prevention of diseases associated with cellular aging and oxidative stress.
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